Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,274 | -9,737 | -25,329 | -17,602 | -11,171 |
| Accounts payable and accrued liabilities | -2,788 | 192 | 3,273 | 1,158 | 214 |
| Other Working Capital | -5,072 | -3,432 | -1,137 | -3,796 | -3,885 |
| Other Operating Activity | 5,902 | 1,351 | 5,879 | 6,537 | 5,125 |
| Operating Cash Flow | $-21,233 | $-11,626 | $-17,313 | $-13,704 | $-9,716 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,580 | N/A | 5 | 5 | N/A |
| Other Financing Activity | 0 | 7 | 0 | 0 | 5 |
| Financing Cash Flow | $8,580 | $7 | $5 | $5 | $5 |
| Beginning Cash Position | 28,378 | 28,378 | 45,686 | 45,686 | 45,686 |
| End Cash Position | 15,725 | 16,759 | 28,378 | 31,987 | 35,974 |
| Net Cash Flow | $-12,653 | $-11,619 | $-17,308 | $-13,699 | $-9,712 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,233 | -11,626 | -17,313 | -13,704 | -9,716 |
| Free Cash Flow | -21,233 | -11,626 | -17,313 | -13,704 | -9,716 |